I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.

Howard Yu Biography and Net Worth

CFO of Envista

As Envista’s CFO, Howard Yu leads the corporate financial organization for the company.

Howard joined Danaher in 2001 as Corporate Finance Manager at Beckman Coulter. Over the course of 13 years he held several leadership positions, including VP of Finance. He was named CFO of Ormco in 2014 and CFO of Nobel Biocare in 2017.

Prior to joining Danaher, Howard worked in finance at Hewlett-Packard and Deloitte and Touche.

Howard received a BA in Business Economics from UCLA and an MBA from the University of Southern California. He is a licensed CPA in the state of California and lives in Orange County, California.

What is Howard H. Yu's net worth?: The estimated net worth of Howard H. Yu is at least $882,442.60 as of February 28th, 2023. Mr. Yu owns 45,865 shares of Envista stock worth more than $882,443 as of December 18th. This net worth evaluation does not reflect any other investments that Mr. Yu may own. Learn More about Howard H. Yu's net worth.
How do I contact Howard H. Yu?: The corporate mailing address for Mr. Yu and other Envista executives is 200 S. KRAEMER BLVD. BUILDING E, BREA CA, 92821. Envista can also be reached via phone at 714-817-7000 and via email at [email protected]. Learn More on Howard H. Yu's contact information.
Has Howard H. Yu been buying or selling shares of Envista?: Howard H. Yu has not been actively trading shares of Envista during the last quarter. Most recently, Howard H. Yu sold 10,016 shares of the business's stock in a transaction on Tuesday, February 28th. The shares were sold at an average price of $37.90, for a transaction totalling $379,606.40. Following the completion of the sale, the chief financial officer now directly owns 45,865 shares of the company's stock, valued at $1,738,283.50. Learn More on Howard H. Yu's trading history.
Who are Envista's active insiders?: Envista's insider roster includes Amir Aghdaei (CEO), Curt Bludworth (Insider), Eric Conley (SVP), Eric Hammes (CFO), Jeffrey Kappler (SVP), Stephen Keller (Principal Financial Officer), Mark Nance (General Counsel), Mischa Reis (SVP), and Howard Yu (CFO). Learn More on Envista's active insiders.
Are insiders buying or selling shares of Envista?: During the last twelve months, Envista insiders bought shares 1 times. They purchased a total of 24,532 shares worth more than $400,607.56. The most recent insider tranaction occured on August, 12th when CFO Eric D Hammes bought 24,532 shares worth more than $400,607.56. Insiders at Envista own 1.3% of the company. Learn More about insider trades at Envista.
Information on this page was last updated on 8/12/2024.

Howard H. Yu Insider Trading History at Envista

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/28/2023	Sell	10,016	$37.90	$379,606.40	45,865
11/17/2022	Sell	657	$36.55	$24,013.35	51,106
4/18/2022	Sell	5,341	$45.73	$244,243.93	52,411
2/25/2022	Sell	3,598	$47.81	$172,020.38
12/23/2021	Sell	3,954	$45.07	$178,206.78
11/17/2021	Sell	657	$42.30	$27,791.10
5/7/2021	Sell	35,021	$45.17	$1,581,898.57	66,297
4/7/2021	Sell	1,702	$45.00	$76,590.00	59,987
3/22/2021	Sell	24,421	$40.78	$995,888.38	76,963
9/20/2019	Buy	2,000	$22.00	$44,000.00

Howard H. Yu Buying and Selling Activity at Envista

Envista Company Overview

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products. This segment also provides software packages, which include DTX Studio Implant; DTX Studio Lab; and DTX Studio Clinic, a software package offered with its imaging products. It offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.

Today's Range

Now: $19.24

$18.93

$19.64

50 Day Range

MA: $20.12

$17.70

$22.33

2 Week Range

Now: $19.24

$15.15

$25.64

Volume

1,886,989 shs

Average Volume

2,364,804 shs

Market Capitalization

$3.31 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.31

I was wrong. Dead wrong.

From Porter & Company | Ad